Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure.
about
Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failurePeripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptidesEarly neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability.Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.Therapeutic potential of neuropeptide Y (NPY) receptor ligands.NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4Roles of nuclear NPY and NPY receptors in the regulation of the endocardial endothelium and heart function.Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium.Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.Neuromodulators of peripheral cardiac sympatho-vagal balance.Autonomic control of the heart: going beyond the classical neurotransmittersMolecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease.The Role of Neuropeptide Y in Cardiovascular Health and Disease
P2860
Q26829634-D501F6DD-9AE0-41BF-A338-28EA7D2E4FC7Q27026280-02659053-D9FA-4D71-8251-13C2756219F1Q31863980-91FD6DDF-8947-45E4-955C-58C9AEF856AEQ34681621-E3D35C30-C068-4BE5-8020-B8851704187AQ34718326-A25118C7-5D50-46D8-9A13-B885306E2EA5Q35859570-B18B7337-33FA-4B5C-940A-60FCC1DFDE9CQ35872380-6014F34C-5000-4764-AFB2-81A6BD88B087Q36088880-1D3E4D76-6068-44DF-B244-BB8584FA06AEQ36339460-7BE1BB8A-C82B-438C-9A61-8745ED213042Q36602618-CB43BD30-B783-4A7B-AC79-4DE24A9802B9Q36812699-FB15BF4E-8403-4345-8A13-076B10095D68Q36814747-3C0B334A-9308-4E4D-8163-FFC0DCEBA0A0Q37158344-0331C2CD-68C8-4511-B911-58A24AAF0FA5Q37306260-0A37C6A8-4BE9-4DA6-882D-7C6B5B531644Q38262604-AA0BD976-86A4-4A85-9C54-C1C4A7CD5049Q40722220-310428E3-7B82-405D-878B-846E0F2F79E7Q57073005-A4DFBFC4-23CE-4893-A1A0-5C1292EC9CE9
P2860
Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Plasma neuropeptide Y on admis ...... ients with left heart failure.
@en
Plasma neuropeptide Y on admis ...... ients with left heart failure.
@nl
type
label
Plasma neuropeptide Y on admis ...... ients with left heart failure.
@en
Plasma neuropeptide Y on admis ...... ients with left heart failure.
@nl
prefLabel
Plasma neuropeptide Y on admis ...... ients with left heart failure.
@en
Plasma neuropeptide Y on admis ...... ients with left heart failure.
@nl
P2093
P356
P1476
Plasma neuropeptide Y on admis ...... ients with left heart failure.
@en
P2093
Franco-Cereceda A
Lundberg JM
P304
P356
10.1093/CVR/24.2.102
P577
1990-02-01T00:00:00Z